Arabic version: العيادات البريطانية تحت المراقبة بسبب ادعاءات الببتيد غير المنظمة

The Medicines and Healthcare products Regulatory Agency (MHRA) is investigating UK clinics that promote unregulated peptide therapies, which are claimed to aid in weight loss, anti-ageing, and injury recovery. According to The Guardian, the regulator is assessing whether these clinics are violating laws by making medicinal claims about their treatments.

The surge in interest surrounding peptides has led numerous clinics to offer these experimental therapies, often without substantial scientific backing. Many claims made by these clinics lack evidence from large-scale clinical trials, with most studies conducted on animals or in laboratory settings.

The MHRA has clarified that clinics cannot make medicinal claims regarding peptide injections. If they do, these products would be classified as medicines and subject to strict regulations under the Human Medicines Regulations 2012. The agency has indicated that it will take action against any clinics found to be in violation of these requirements.

Some clinics have been found to advertise peptides with specific benefits, such as cognitive enhancement and tissue repair. In response to inquiries, one clinic removed these claims from its website after being approached by a Guardian reporter. Another clinic acknowledged the lack of extensive clinical trials while still promoting multiple peptides and their purported benefits.

The MHRA’s investigation is crucial as it aims to ensure that consumers are not misled about the safety and efficacy of peptide therapies. The agency is committed to enforcing regulations to protect public health in the rapidly evolving landscape of peptide treatments.